Hepatitis C Treatment Experiences and Decision Making Among Patients Living With HIV Infection

Carol Bova, Lisa Fink Ogawa, Susan Sullivan-Bolyai

Research output: Contribution to journalArticle

Abstract

Hepatitis C infection is a major problem for approximately 250,000 HIV-infected persons in the United States. Although HIV infection is well-controlled in most of this population, they suffer liver-associated morbidity and mortality. Conversely, hepatitis C virus (HCV) treatment uptake remains quite low (15%-30%). Therefore, the purpose of this qualitative study was to explore HCV treatment experiences and decision making in adults with HIV infection. The study sample included 39 coinfected adults; 16 in the HCV-treated cohort (who were interviewed a maximum of 3 times) and 23 in the HCV-nontreatment cohort. Analysis of interviews identified 2 treatment barriers (fears and vicarious experiences) and 4 facilitating factors (experience with illness management, patient-provider relationships, gaining sober time, and facing treatment head-on). Analysis of these data also revealed a preliminary model to guide intervention development and theoretical perspectives. Ultimately, research is urgently needed to test interventions that improve HCV evaluation and treatment uptake among HIV-infected patients.

Original languageEnglish (US)
Pages (from-to)63-74
Number of pages12
JournalThe Journal of the Association of Nurses in AIDS Care : JANAC
Volume21
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Hepatitis C
Hepacivirus
HIV Infections
Decision Making
HIV
Therapeutics
Fear
Head
Interviews
Morbidity
Mortality
Liver
Infection
Research
Population

Keywords

  • decision making
  • hepatitis C
  • HIV

ASJC Scopus subject areas

  • Advanced and Specialized Nursing

Cite this

Hepatitis C Treatment Experiences and Decision Making Among Patients Living With HIV Infection. / Bova, Carol; Ogawa, Lisa Fink; Sullivan-Bolyai, Susan.

In: The Journal of the Association of Nurses in AIDS Care : JANAC, Vol. 21, No. 1, 01.2010, p. 63-74.

Research output: Contribution to journalArticle

@article{7959fdd542b34f1e961cee6a6eca1940,
title = "Hepatitis C Treatment Experiences and Decision Making Among Patients Living With HIV Infection",
abstract = "Hepatitis C infection is a major problem for approximately 250,000 HIV-infected persons in the United States. Although HIV infection is well-controlled in most of this population, they suffer liver-associated morbidity and mortality. Conversely, hepatitis C virus (HCV) treatment uptake remains quite low (15{\%}-30{\%}). Therefore, the purpose of this qualitative study was to explore HCV treatment experiences and decision making in adults with HIV infection. The study sample included 39 coinfected adults; 16 in the HCV-treated cohort (who were interviewed a maximum of 3 times) and 23 in the HCV-nontreatment cohort. Analysis of interviews identified 2 treatment barriers (fears and vicarious experiences) and 4 facilitating factors (experience with illness management, patient-provider relationships, gaining sober time, and facing treatment head-on). Analysis of these data also revealed a preliminary model to guide intervention development and theoretical perspectives. Ultimately, research is urgently needed to test interventions that improve HCV evaluation and treatment uptake among HIV-infected patients.",
keywords = "decision making, hepatitis C, HIV",
author = "Carol Bova and Ogawa, {Lisa Fink} and Susan Sullivan-Bolyai",
year = "2010",
month = "1",
doi = "10.1016/j.jana.2009.07.009",
language = "English (US)",
volume = "21",
pages = "63--74",
journal = "Journal of the Association of Nurses in AIDS Care",
issn = "1055-3290",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Hepatitis C Treatment Experiences and Decision Making Among Patients Living With HIV Infection

AU - Bova, Carol

AU - Ogawa, Lisa Fink

AU - Sullivan-Bolyai, Susan

PY - 2010/1

Y1 - 2010/1

N2 - Hepatitis C infection is a major problem for approximately 250,000 HIV-infected persons in the United States. Although HIV infection is well-controlled in most of this population, they suffer liver-associated morbidity and mortality. Conversely, hepatitis C virus (HCV) treatment uptake remains quite low (15%-30%). Therefore, the purpose of this qualitative study was to explore HCV treatment experiences and decision making in adults with HIV infection. The study sample included 39 coinfected adults; 16 in the HCV-treated cohort (who were interviewed a maximum of 3 times) and 23 in the HCV-nontreatment cohort. Analysis of interviews identified 2 treatment barriers (fears and vicarious experiences) and 4 facilitating factors (experience with illness management, patient-provider relationships, gaining sober time, and facing treatment head-on). Analysis of these data also revealed a preliminary model to guide intervention development and theoretical perspectives. Ultimately, research is urgently needed to test interventions that improve HCV evaluation and treatment uptake among HIV-infected patients.

AB - Hepatitis C infection is a major problem for approximately 250,000 HIV-infected persons in the United States. Although HIV infection is well-controlled in most of this population, they suffer liver-associated morbidity and mortality. Conversely, hepatitis C virus (HCV) treatment uptake remains quite low (15%-30%). Therefore, the purpose of this qualitative study was to explore HCV treatment experiences and decision making in adults with HIV infection. The study sample included 39 coinfected adults; 16 in the HCV-treated cohort (who were interviewed a maximum of 3 times) and 23 in the HCV-nontreatment cohort. Analysis of interviews identified 2 treatment barriers (fears and vicarious experiences) and 4 facilitating factors (experience with illness management, patient-provider relationships, gaining sober time, and facing treatment head-on). Analysis of these data also revealed a preliminary model to guide intervention development and theoretical perspectives. Ultimately, research is urgently needed to test interventions that improve HCV evaluation and treatment uptake among HIV-infected patients.

KW - decision making

KW - hepatitis C

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=72149130029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72149130029&partnerID=8YFLogxK

U2 - 10.1016/j.jana.2009.07.009

DO - 10.1016/j.jana.2009.07.009

M3 - Article

VL - 21

SP - 63

EP - 74

JO - Journal of the Association of Nurses in AIDS Care

JF - Journal of the Association of Nurses in AIDS Care

SN - 1055-3290

IS - 1

ER -